Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Free Cash Flow (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Free Cash Flow for 15 consecutive years, with -$119.6 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow fell 6.53% year-over-year to -$119.6 million; the TTM value through Mar 2026 reached -$380.6 million, up 5.77%, while the annual FY2025 figure was -$373.3 million, 4.67% up from the prior year.
  • Free Cash Flow hit -$119.6 million in Q1 2026 for Agios Pharmaceuticals, down from -$96.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$62.0 million in Q3 2023 and bottomed at -$134.8 million in Q4 2024.
  • Average Free Cash Flow over 5 years is -$88.0 million, with a median of -$84.2 million recorded in 2024.
  • Year-over-year, Free Cash Flow crashed 85.35% in 2024 and then increased 28.66% in 2025.
  • Agios Pharmaceuticals' Free Cash Flow stood at -$66.3 million in 2022, then dropped by 9.73% to -$72.7 million in 2023, then plummeted by 85.35% to -$134.8 million in 2024, then rose by 28.66% to -$96.2 million in 2025, then decreased by 24.36% to -$119.6 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$119.6 million, -$96.2 million, and -$86.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.